NEXT Life Sciences published a coverage article by Laura Simmons of IFLScience discussing clinical study results for Plan A™ for Men and PausePill™ by Founder and Executive Chairman L.R. Fox.
Public source
Publisher name
Public post
“We could see a radical shift in the birth control landscape that will leave people of the future in mystified horror that we ever lived this way.” - Laura Simmons In th…
Company
NEXT Life Sciences
NEXT Life Sciences is advancing a pipeline of de-risked and transformative reproductive & sexual health products.
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
About NEXT Life Sciences
NEXT Life Sciences is a reproductive health platform company advancing a portfolio of medical device and pharmaceutical products designed to address significant unmet needs in reproductive and sexual health. Along with other reproductive products, the company’s two lead male contraceptives are Plan A™, a long-acting, non-hormonal, and reversible on-demand male contraceptive, and PausePill™, an on-demand, non-hormonal male contraceptive pill. For more information, visit nextlifesciences.org and planaformen.com
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
NEXT Global Capital, Inc.
NEXT Global Capital, Inc. announced that the company is conducting Phase II clinical trials for a long acting, reversible on-demand male birth control pill.
Research & Knowledge
Daré Bioscience, Inc.
Daré Bioscience, Inc. published new data on DARE to PLAY showing that women using topical sildenafil cream saw plasma drug levels roughly two orders of magnitude lower than oral doses in men, with no cardiac-related side effects reported.
Research & Knowledge
Population Council
Population Council published new research in Scientific Reports investigating the anti-STI potential of copper sulfate, zinc lactate, and lactic acid to target viral and bacterial STIs.
Research & Knowledge
Path Fertility
Path Fertility published a GQ article detailing the gap between a normal male infertility workup and actual fertility issues, highlighting the need for more research funding and options for couples.
Research & Knowledge
CleopatraRX